IFI44L serves as a tumor suppressor in hepatocellular carcinoma; in hepatocellular carcinoma patients, low IFI44L expression is associated with tumor size, recurrence, advanced stage and poor clinical survival [60]. This evidence concerns the gene IFI44L and hepatocellular carcinoma.